Nuzenio

Viridian Therapeutics Inc

Viridian Therapeutics Inc news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 18 latest news signals 10 publisher sources 100/100 entity strength

Latest news

VRDN SWOT Analysis: Financial Challenges and Growth Potential Re - GuruFocusGuruFocus · Sat, 08 Aug 2026 05:27:18 GMTVRDN Maintained by RBC Capital -- Price Target Raised to $36.00 - GuruFocusGuruFocus · Fri, 07 Aug 2026 22:56:08 GMTViridian Therapeutics to See 'Minimal' Revenue Growth in H2, RBC Capital Markets Says - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 16:05:30 GMTState Street Corporation (NASDAQ: VRDN) discloses 5.5% Viridian Therapeutics ownership - Stock TitanStock Titan · Fri, 07 Aug 2026 15:13:34 GMTRBC Adjusts Viridian Therapeutics PT to $36 From $35, Maintains Outperform Speculative Risk Rating - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 13:28:20 GMTA Quick Look at Today's Ratings for Viridian Therapeutics(VRDN.US), With a Forecast Between $22 to $41 - MoomooMoomoo · Fri, 07 Aug 2026 13:00:02 GMTWilliam Blair Maintains Viridian Therapeutics(VRDN.US) With Buy Rating - MoomooMoomoo · Fri, 07 Aug 2026 04:35:17 GMTViridian Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Thu, 06 Aug 2026 14:01:33 GMT

Timeline

Sat, 08 Aug 2026 05:27:18 GMTVRDN SWOT Analysis: Financial Challenges and Growth Potential Re - GuruFocus
Fri, 07 Aug 2026 22:56:08 GMTVRDN Maintained by RBC Capital -- Price Target Raised to $36.00 - GuruFocus
Fri, 07 Aug 2026 16:05:30 GMTViridian Therapeutics to See 'Minimal' Revenue Growth in H2, RBC Capital Markets Says - Yahoo Finance
Fri, 07 Aug 2026 15:13:34 GMTState Street Corporation (NASDAQ: VRDN) discloses 5.5% Viridian Therapeutics ownership - Stock Titan
Fri, 07 Aug 2026 13:28:20 GMTRBC Adjusts Viridian Therapeutics PT to $36 From $35, Maintains Outperform Speculative Risk Rating - Yahoo Finance
Fri, 07 Aug 2026 13:00:02 GMTA Quick Look at Today's Ratings for Viridian Therapeutics(VRDN.US), With a Forecast Between $22 to $41 - Moomoo

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Viridian Therapeutics Inc.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

10 distinct publisher/source names are currently connected to this entity page.